Find information on thousands of medical conditions and prescription drugs.

Hypogonadism

Hypogonadism is a medical term for a defect of the reproductive system which results in lack of function of the gonads (ovaries or testes). The gonads have two functions: to produce hormones (testosterone, estradiol, antimullerian hormone, progesterone, inhibin B), activin and to produce gametes (eggs or sperm). Deficiency of sex hormones can result in defective primary or secondary sexual development, or withdrawal effects (e.g., premature menopause) in adults. Defective egg or sperm development results in infertility. more...

Home
Diseases
A
B
C
D
E
F
G
H
Hairy cell leukemia
Hallermann Streiff syndrome
Hallux valgus
Hantavirosis
Hantavirus pulmonary...
HARD syndrome
Harlequin type ichthyosis
Harpaxophobia
Hartnup disease
Hashimoto's thyroiditis
Hearing impairment
Hearing loss
Heart block
Heavy metal poisoning
Heliophobia
HELLP syndrome
Helminthiasis
Hemangioendothelioma
Hemangioma
Hemangiopericytoma
Hemifacial microsomia
Hemiplegia
Hemoglobinopathy
Hemoglobinuria
Hemolytic-uremic syndrome
Hemophilia A
Hemophobia
Hemorrhagic fever
Hemothorax
Hepatic encephalopathy
Hepatitis
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D
Hepatoblastoma
Hepatocellular carcinoma
Hepatorenal syndrome
Hereditary amyloidosis
Hereditary angioedema
Hereditary ataxia
Hereditary ceroid...
Hereditary coproporphyria
Hereditary elliptocytosis
Hereditary fructose...
Hereditary hemochromatosis
Hereditary hemorrhagic...
Hereditary...
Hereditary spastic...
Hereditary spherocytosis
Hermansky-Pudlak syndrome
Hermaphroditism
Herpangina
Herpes zoster
Herpes zoster oticus
Herpetophobia
Heterophobia
Hiccups
Hidradenitis suppurativa
HIDS
Hip dysplasia
Hirschsprung's disease
Histoplasmosis
Hodgkin lymphoma
Hodgkin's disease
Hodophobia
Holocarboxylase...
Holoprosencephaly
Homocystinuria
Horner's syndrome
Horseshoe kidney
Howell-Evans syndrome
Human parvovirus B19...
Hunter syndrome
Huntington's disease
Hurler syndrome
Hutchinson Gilford...
Hutchinson-Gilford syndrome
Hydatidiform mole
Hydatidosis
Hydranencephaly
Hydrocephalus
Hydronephrosis
Hydrophobia
Hydrops fetalis
Hymenolepiasis
Hyperaldosteronism
Hyperammonemia
Hyperandrogenism
Hyperbilirubinemia
Hypercalcemia
Hypercholesterolemia
Hyperchylomicronemia
Hypereosinophilic syndrome
Hyperhidrosis
Hyperimmunoglobinemia D...
Hyperkalemia
Hyperkalemic periodic...
Hyperlipoproteinemia
Hyperlipoproteinemia type I
Hyperlipoproteinemia type II
Hyperlipoproteinemia type...
Hyperlipoproteinemia type IV
Hyperlipoproteinemia type V
Hyperlysinemia
Hyperparathyroidism
Hyperprolactinemia
Hyperreflexia
Hypertension
Hypertensive retinopathy
Hyperthermia
Hyperthyroidism
Hypertrophic cardiomyopathy
Hypoaldosteronism
Hypocalcemia
Hypochondrogenesis
Hypochondroplasia
Hypoglycemia
Hypogonadism
Hypokalemia
Hypokalemic periodic...
Hypoparathyroidism
Hypophosphatasia
Hypopituitarism
Hypoplastic left heart...
Hypoprothrombinemia
Hypothalamic dysfunction
Hypothermia
Hypothyroidism
Hypoxia
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

The term hypogonadism is usually applied to permanent rather than transient or reversible defects, and usually implies deficiency of reproductive hormones, with or without fertility defects. The term is less commonly used for infertility without hormone deficiency.

Read more at Wikipedia.org


[List your site here Free!]


Depression in men with age-associated hypogonadism
From American Family Physician, 11/1/04 by Karl E. Miller

After men reach the age of 40 years, testosterone levels decline approximately 1 percent per year. This decline can lead to age-associated testosterone deficiency, which is present in 30 percent of men 55 years or older. Testosterone levels have also been shown to decline with severe illnesses, malnutrition, or drug use, particularly corticosteroids and alcohol. Men with age-associated hypogonadism have total testosterone levels of 150 to 350 ng per dL (5.20 to 12.13 nmol per L). Symptoms related to hypogonadism include diminished muscle mass and strength, anorexia, decreased libido, decreased bone mineral density, fatigue, dysphoria, and irritability.

Several studies have examined the relationship between testosterone levels and depression, but the results have been inconsistent. In addition, studies evaluating the use of testosterone in the treatment of depression in men with low testosterone levels have not yielded consistent results. Shores and associates conducted a study to determine if hypogonadal men have an increased incidence of depressive illness compared with men who have normal testosterone levels.

The trial design was a historical cohort study using computerized medical records from a regional veterans' health care system. Inclusion criteria were an age of 45 years or older, at least two visits to the medical center each year, available baseline and follow-up testosterone levels separated by at least one year, and stable testosterone levels. Subjects were excluded if they had a diagnosis of depressive illness or were treated with anti-androgens. The researchers used a total testosterone level of 200 ng per dL (6.93 nmol per L) or less or a free testosterone level of 0.9 ng per dL (0.03 nmol per L) or less as their threshold for diagnosing hypogonadism.

The next step was to identify patients who had a clinically diagnosed depressive illness during the past two years. Demographic information and comorbidities were extracted from the records. A manual record review was performed by a person who was blinded to the testosterone levels. A psychiatrist who also was blinded to the testosterone levels then conducted a comprehensive review of the patient records to identify those with depressive illnesses.

There were 278 men who met the inclusion and exclusion criteria, had consistent normal or low testosterone levels at baseline and during the two-year follow-up, and did not have a history of depressive illness. The incidence of diagnosed depressive illnesses was significantly higher in men who had testosterone levels that met the criteria for hypogonadism (21.7 percent) than in men who had normal testosterone levels (7.1 percent).

The data were analyzed using Cox proportional hazards regression models to examine the association between hypogonadism and time to depression. The unadjusted hazard ratio for depression in men with hypogonadism was 3.5. After adjustment for all covariates, including age, race, number of clinic visits, alcohol use, prostate cancer, and overall medical comorbidity, the hazard ratio was 4.2.

The authors conclude that men with hypogonadism had an increased incidence of depressive illnesses and a shorter time to diagnosis of depression. They add that their study does not address the issue of using testosterone to treat or augment treatment for depression in men with hypogonadism.

KARL E. MILLER, M.D.

Shores MM, et al. Increased incidence of diagnosed depressive illness in hypogonadal older men. Arch Gen Psychiatry February 2004;61:162-7.

COPYRIGHT 2004 American Academy of Family Physicians
COPYRIGHT 2004 Gale Group

Return to Hypogonadism
Home Contact Resources Exchange Links ebay